India trying to save vaccines by delaying shots for Covid patients: Government panel

India is trying to save scarce Covid-19 vaccines by delaying shots for those who have recovered from the disease, the head of a government panel said, adding the campaign should not have been opened to all adults before covering the most vulnerable.

Under fire for his handling of the world’s worst rise in coronavirus infections, Prime Minister Narendra Modi made all adults eligible for vaccination from May 1.

Vaccine shortages have now forced many regions, including the capital New Delhi, to again prioritise those aged above 45.

The federal government on Wednesday said patients should go for their vaccination three months after recovery, compared with the earlier recommendation of about one month. It did not give a reason.

“It’s been done to save vaccine doses,” Narendra Kumar Arora, head of the government’s National Technical Advisory Group on Immunisation, told Reuters on Friday. “We discussed delaying it by three months, six months or nine months, but finally we said ‘we can manage it with three months, let’s do three months for now'”.

Arora said that given the vaccine shortage in India, the focus should have been on immunising the most at risk.

“Our group prioritised those aged 45 or more,” he said. “Because 75% of the mortality and morbidity is in that age group.”

The Ministry of Health and Family Welfare said on April 19 that the decision to include all adults in the immunisation campaign was taken in a meeting chaired by Modi.

The ministry and Modi’s office did not respond to a request for comment.

India has administered about 192 million doses, the most after China and the United States, but given the necessary two doses to only about 3% of its 1.35 billion people.

  • Related Posts

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    New Delhi: A joint operation by the Delhi Police Crime Branch, the Central Drugs Standard Control Organisation (CDSCO) and the Gautam Buddha Nagar District Drug Department uncovered a suspected illegal…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Pharma companies in a flux over Trump’s 200% tariff move on generics

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    Fake Medicines Worth Over Rs 5 Crore Seized From Factory In Uttarakhand’s Dehradun

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    CDSCO declares 159 drug samples as NSQs in June

    CDSCO declares 159 drug samples as NSQs in June